A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Obsidian Therapeutics, Inc.
Filamon LTD
Replimune Inc.
Medicenna Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Klus Pharma Inc.
Revolution Medicines, Inc.
Exicure, Inc.
Allarity Therapeutics
Dynavax Technologies Corporation
Lumos Pharma
Aprea Therapeutics
Incyte Corporation
Ascend Biopharmaceuticals Ltd